Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer), confirmed either through specialised liver imaging (CT or MRI) or a tissue biopsy
- People whose liver cancer has been assessed by their medical team as suitable for a procedure called TACE (a treatment that delivers medicine directly to liver tumours through blood vessels), based on standard liver cancer staging guidelines
- People whose liver is functioning at a certain level, measured by a scoring system called Child-Pugh — specifically, those with a score of 7 or lower at the time TACE is recommended
- People who are fully active and able to carry out all normal daily activities without restriction (this is measured using a standard scale called ECOG, and a score of 0 is required)
- People who have had at least one follow-up CT or MRI scan taken 4 to 8 weeks after their TACE procedure
Who may not be able to join:
- People with a Child-Pugh score of 8 or higher at the time TACE is recommended, indicating more significant liver impairment
- People who are not fully active in daily life at the time TACE is recommended (ECOG score greater than 0)
- People whose cancer has spread outside the liver, or where cancer has grown into major blood vessels
- People for whom the TACE procedure is not technically possible — for example, where doctors are unable to identify the blood vessel supplying the tumour
- People with serious blood clotting problems or very low blood cell counts that cannot be corrected
- People with a severe allergy or medical reason to avoid the contrast dye or medications used during the TACE procedure
- People who are pregnant or breastfeeding
- People who are unable to provide signed consent to participate in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 00381601435353
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Correlation between blood-based biomarkers and early radiological response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.